Journal article
Two contrasting papers stimulate a commentary on the origins of tumour immunology, current cancer immunotherapies, and the future potential for cancer immunotherapy
- Abstract:
- Two early papers expressing conflicting views on the occurrence of effective immune attack against cancers stimulate an analysis of the gradual development of an understanding of tumour biology. This understanding has led to the development of the strikingly effective check point blocking and CART anti-cancer immunotherapies, and the promise of more widely applicable therapies based on T cell attracting genetically engineered monoclonal antibodies.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 250.1KB, Terms of use)
-
- Publisher copy:
- 10.1038/s41416-022-02075-z
Authors
- Publisher:
- Springer Nature [academic journals on nature.com]
- Journal:
- British Journal of Cancer More from this journal
- Volume:
- 128
- Issue:
- 3
- Pages:
- 419-420
- Publication date:
- 2022-12-07
- DOI:
- EISSN:
-
1532-1827
- ISSN:
-
0007-0920
- Language:
-
English
- Keywords:
- Pubs id:
-
1313529
- Local pid:
-
pubs:1313529
- Source identifiers:
-
W4310962198
- Deposit date:
-
2026-04-30
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2022
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record